Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat

Journal of Neurotrauma

Volumn 13, Issue 12, 1996, Pages 767-780

  McIntosh, Tracy K ^a   Smith, Douglas H ^a   Voddi, Madhu ^a   Perri, Brian R ^a   Stutzmann, Jean Marie ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SANOFI   (France)

Author keywords

brain injury; cognition; edema; excitotoxicity; glutamate; neuroprotection; rat

Indexed keywords

GLYCOL; NEUROPROTECTIVE AGENT; RILUZOLE; SODIUM CHANNEL BLOCKING AGENT; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMORY; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030468988     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.767     Document Type: Article

References (87)

1. ALAOUI, F., PRATT, J., STUTZMANN, J.-M., and COURT, L. (1995). Acute effects of irradiation of the rat brain: Protection by glutamate blockade. Eur. J. Pharmacol. 276, 55-60.
2. BENAVIDES, J., CAMELIN, J.C., MITRANI, N., et al. (1985). 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmisston - II Biochemical properties. Neuropharmacology 24, 1085-1092.
3. BENAZZOUZ, A., BORAUD, T., DUBEDAT, P., BOIREAU, A., STUTZMANN, J.-M., and GROSS, C. (1995). Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: A pilot study. Eur. J. Pharmacol. 284, 299-307.
4. + channels in myelinated nerve fiber. Pflüger Arch. 419, 603-609.
5. BENSIMON, G., LACOMBLEZ, L., MEININGER, V., and ALS/RILUZOLE STUDY GROUP (1994). A controlled trial of Riluzole in amyotrophic lateral sclerosis. N. Engl. J. Med. 330, 585-591.
6. BOIREAU, A., MIQUET, J.M., DUBEDAT, P., MEUNIER, M., and DOBLE, A. (1994). Riluzole and experimental parkinsonism: Partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo. NeuroReport 5, 2157-2160.
7. CLIFTON, G.L., JIANG, J.Y., LYETH, B.C., JENKINS, L.W., HAMM, R.J., and HAYES, R.L. (1991). Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11, 114-121.
8. CLINESCHMIDT, B.V., MARTIN, G.E., and BUNTING, P.R. (1982). Anticonvulsant activity of MK 801, a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2, 123-134.
9. CORBETT, D., EVANS, S., THOMAS, C., WANG, D., and JONES, R.A. (1990). MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res. 514, 300-304.
10. CORTEZ, S.C., MCINTOSH, T.K., and NOBLE, L. (1989). Experimental fluid percussion brain injury: Vascular disruption and neuronal and glial alterations. Brain Res. 482, 271-282.
11. DEBONO, M.W., LE GUERN, J., CANTON, T., DOBLE, A., and PRADIER, L. (1993). Inhibition by Riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 235, 283-289.
12. DIETRICH, W.D., ALONSO, O., and HALLEY, M. (1994a). Early microvascular and neuronal consequences of traumatic brain injury: A light and electron microscopic study in rats. J. Neurotrauma 11, 289-301.
13. DIETRICH, W.D., ALONSO, O., MORDECAI, R.B., GLOBUS, Y.T., and GINSBERG, M.D. (1994b). Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol. (Berl.) 87, 250-258.
14. DIXON, C.E., LYETH, B.C., POVLISHOCK, J.T., et al. (1987). A fluid percussion model of experimental brain injury in the rat: Neurological, physiological, and histopathological characteristics. J. Neurosurg. 67, 110-119.
15. DOBLE, A. (1996). The pharmacology and mechanism of action of Riluzole. Neurology. In press.
16. 3H]aspartate release from cultured cerebellar granule cells. Neurosci. Lett. 140, 251-254.
17. DOBLE, A., and PERRIER, M.L. (1989). Pharmacology of excitatory amino acid receptors coupled to inositol phosphate metabolism in neonatal rat striatum. Neurochem. Int. 15, 1-8.
18. ESTEVEZ, A.G., STUTZMANN, J.-M, and BARBEITO, L. (1995). Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur. J. Pharmacol. 280, 47-53.
19. FADEN, A.I. (1993). Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7, 175-186.
20. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 789-800.
21. GRAHAM, S.H., CHEN, J., LAN, J., LEACH, J., and SIMON, R.P. (1993a). Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channel, BW619C89, in rat middle cerebral artery occlusion. J. Pharmacol. Exp. Ther. 13, 88-97.
22. GRAHAM, S.H., CHEN, J., SHARP, F.R., and SIMON, R.P. (1993b). Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13, 88-97.
23. HAMM, R.J., DIXON, C.E., GBADEBO, D.M., et al. (1992). Cognitive deficits following traumatic brain injury by controlled cortical impact. J. Neurotrauma 9, 11-20.
24. HAMM, R.J., LYETH, B.G., JENKINS, L.W., O'DELL, D.M., and PIKE, B.R. (1993a). Selective cognitive impairment following traumatic brain injury in rats. Behav. Brain Res. 59, 169-173.
25. HAMM, R.J., O'DELL, D.M., PIKE, B.R., and LYETH, B.C. (1993b). Cognitive impairment following traumatic brain injury: The effect of pre- and post-injury administration of scopolamine and MK-801. Cog. Brain Res. 1, 223-226.
26. HAYES, R.L., JENKINS, L.W., LYETH, B.C., et al. (1988). Pretreatment with phencyclidine, an N-methyl-D-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J. Neurotrauma 5, 259-274.
27. HAYWARD, N.J., MCKNIGHT, A.T., and WOODRUFF, G.N. (1993). Brain temperature and the neuroprotective action of enadoline and dizocilpine in the gerbil model of global ischaemia. Eur. J. Pharmacol. 236, 247-253.
28. HEBERT, T., DRAPEAU, L., PRADIER, L., and DUNN, R.J. (1994). Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug Riluzole. Mol. Pharmacol. 45, 1055-1060.
29. HICKS, R.R., SMITH, D.H., LOWENSTEIN, D.H., SAINT MARIE, R.L., and MCINTOSH, T.K. (1993). Mild experimental brain injury in the rat induces cognitive defects associated with regional neuronal loss in the hippocampus. J. Neurotrauma 10, 405-414.
30. HICKS, R.R., SMITH, D.H., and MCINTOSH, T.K. (1994). Kynurenate is neuroprotective following experimental brain injury in the rat. Brain Res. 655, 91-96.
31. HICKS, R.R., SMITH, D.H., and MCINTOSH, T.K. (1995). Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res. 678, 151-160.
32. HYLTON, C., PERRI, B.R., VODDI, M.D., et al. (1995). Non-NMDA antagonist GYKI 52466 enhances spatial memory after experimental brain injury. J. Neurotrauma 12, 124.
33. JENKLNS, L.W., LYETH, E.G., LEWELT, W., et al. (1988). Combined pretrauma scopolamine and phencyclidine attenuate posttraumatic increased sensitivity to delayed secondary ischemia. J. Neurotrauma 5, 275-287.
34. JIANG, J.Y., LYETH, B.C., KAPASI, M.Z., JENKINS, L.W., and POVLISHOCK, J.T. (1992). Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat. Acta Neuropathol. 84, 495-500.
35. KATAYAMA, Y., BECKER, D.P., TAMURA, T., and HOVDA, D.A. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889-900.
36. KOTAPKA, M.J., GENNARELLI, T.A., GRAHAM, D.I., et al. (1991). Selective vulnerability of hippocampal neurons in acceleration-induced experimental head injury. J. Neurotrauma 8, 247-258.
37. KRAUS, J.F. (1995). Overview in epidemiology of traumatic brain injury. 1 st World Congress on Brain Injury, May 1995, p. 5 (Abstract).
38. LEACH, M.J., SWAN, J.H., EISENTHAL, D., DOPSON, M., and NOBBS, M. (1993). BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24, 1063-1067.
39. LEVIN, H.S. (1985). Outcome after head injury. Part II. Neurobehavioral recovery, in: Status Report on Central Nervous System Trauma Research. National Institute of Neurological and Communicative Disease and Stroke: Bethesda, MD, pp. 281-299.
40. LOWENSTEIN, D.H., SIMON, R.P., and SHARP, F.R. (1990). The pattern of heat shock protein-like immunoreactivity following flurothyl induced status epilepticus. Brain Res. 531, 173-182.
41. LOWENSTEIN, D.H., THOMAS, M.J., SMITH, D.H., and MCINTOSH, T.K. (1992). Selective vulnerability of dentate hilar neurons following traumatic brain injury: A potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12, 4846-4853.
42. LUSTIG, H., VON BRAUCHITSCH, K.L., CHAN, J., and GREENHBERG, D.A. (1992). A novel inhibitor of glutamate release reduces excitotoxic injury in vitro. Neurosci. Lett. 143, 229-232.
43. LYETH, B.C., JENKINS, L.W., HAMM, R.J., et al. (1990). Prolonged memory impairment in the absence of hippocampal cell death following traumatic brain injury in the rat. Brain Res. 526, 249-258.
44. LYETH, B.G., JIANG, J.Y., and LIU, S. (1993). Behavioral protection by moderate hypothermia initiated after experimental traumatic brain injury. J. Neurotrauma 10, 57-64.
45. MALGOURIS, C., BARDOT, F., DANIEL, M., et al. (1989). Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci. 9, 3720-3727.
46. MCINTOSH, T.K. (1994). The neurochemical sequelae of traumatic brain injury: Therapeutic implications. Cerebrovasc. Brain Metab. Rev. 6, 109-162.
47. MCINTOSH, T.K., VINK, R., NOBLE, L., YAMAKAMI, I., FERNYAK, S., and FADEN, A.I. (1989a). Traumatic brain injury in the rat: Characterization of a lateral fluid percussion model. Neuroscience 28, 233-244.
48. MCINTOSH, T.K., VINK, R., SOARES, H.D., HAYES, R.L., and SIMON, R. (1989b). Effect of N-methyl-D-aspartate receptor blocker MK-801 on neurological function after experimental brain injury. J. Neurotrauma 6, 247-259.
49. MCINTOSH, T.K., VINK, R., SOARES, H.D., HAYES, R.L., and SIMON, R. (1990). Effects of non-competitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55, 1170-1179.
50. MCINTOSH, T.K., VINK, R., YAMAKAMI, I., and FADEN, A.I. (1989c). Magnesium protects against neurological deficit after brain injury. Brain Res. 482, 252-260.
51. MELDRUM, B.S., SWAN, J.H., LEACH, M.J., et al. (1992). Reduction of glutamate release and protection against ischemic brain damage by BW1003C87. Brain Res. 593, 1-6.
52. MIYAZAKI, S., NEWLON, P., GOLDBERG, S., et al. (1989). Cerebral concussion suppresses hippocampal long-term potentiation (LTP) on rats, in: Intracranial Pressure VII. A. Marmarou and J. Hoff (eds.) Springer: New York, pp. 651-653.
53. MIZOULE, B., MELDRUM, B., MAZADIER, M., et al. (1985). 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission - I Anticonvulsant properties. Neuropharmacology 24, 767-773.
54. MONAGHAN, D.T., and COTMAN, C. (1986). Identification and properties of N-methyl-D-aspartate receptors in rat brain plasma membranes. Proc. Natl. Acad. Sci. USA 83, 7532-7536.
55. MORRIS, R.G.M. (1984). Developments of a water maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
56. MORRIS, R.G.M., GARRUD, P., RAWLINS, J.N.P., and O'KEEFE, J. (1982). Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
57. NILSSON, P., HILLERED, L., PONTEN, U., and URGERSTEDT, V. (1990). Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10, 631-637.
58. OKIYAMA, K., SMITH, D.H., GENNARELLI, T.A., SIMON, R.P., LEACH, M., and McINTOSH. T.K. (1995). The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J. Neurochem. 64, 802-809.
59. OKIYAMA, K., SMITH, D.H., THOMAS, M.J., and MCINTOSH, T.K. (1992). Evaluation of a novel calcium channel blocker, (s)-emopamil, on regional cerebral edema and neurobehavioral function after experimental brain injury. J. Neurosurg. 77, 607-615.
60. OLNEY, J.W., LABRUYERE, J., and PRICE, M. (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
61. OLTON, D.S., WALKER, J.A., and GAGE, F.H. (1978). Hippocampal connections and spatial discrimination. Brain Res. 139, 295-308.
62. PALMER, A.M., MARION, D.W., BOTSCHELLER, M.L., SWEDLOW. P.E., STYREN, S.D., and DEKOSKY, S.T. (1993). Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J. Neurochem. 61, 2015-2024.
63. PANTER, S.S., and FADEN, A.I. (1992). Pretreatment with the NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci. Lett. 136, 165-168.
64. PARKIN, A.J. (1984). Amnesic syndrome: A lesion-specific disorder? Cortex 20, 479-508.
65. PERRI, B.R., MURAI, H., SMITH, D.H., et al. (1995). A method for rapid quantification of lesion volume in experimental traumatic brain injury using TTC as a histopathologic stain. J. Neurotrauma 12, 481.
66. PRATT, I., RATAUD, J., BARDOT, F., et al. (1992). Neuroprotective actions of Riluzole in rodent models of global and focal cerebral ischaemia. Neurosci. Lett. 140, 225-230.
67. SCOVILLE, W.B., and MILNER, B. (1957). Loss of memory after bilateral hippocampal lesions. J. Neurol. Neurosurg. Psychiatry 20, 11-21.
68. SHAPIRA, Y., YADID, G., COTEV, S., NISKA, A., and SHOHAMI, E. (1990). Protective effect of MK-801 in experimental brain injury. J. Neurotrauma 7, 131-139.
69. SHARP, F., JASPER, P., HALL, J., NOBLE, L., and SAGAR, S.M. (1991). MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann. Neurol. 30, 801-809.
70. SHOHAMI, E., NOVIKOV, M., and BASS, R. (1995). Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674, 44-62.
71. SMITH, D.H., LOWENSTEIN, D.H., GENNARELLI, T.A., and MCINTOSH, T.K. (1994). Persistent memory dysfunction is associated with bilateral hippocampal damage following experimental brain injury. Neurosci. Lett 168, 151-154.
72. SMITH, D.H., OKIYAMA, K., GENNARELLI, T.A., and MCINTOSH, T.K. (1993a). Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci. Lett. 157, 211-214.
73. SMITH, D.H., OKIYAMA, K., THOMAS, M.J., CLAUSSEN, B., and MCINTOSH, T.K. (1991). Evaluation of memory dysfunction following experimental brain injury using the Moms water maze. J. Neurotrauma 8, 259-269.
74. SMITH, D.H., OKIYAMA, K., THOMAS, M.J., and MCINTOSH, T.K. (1993b). Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury. J. Neurosci. 13, 5383-5392.
75. SMITH, D.H., SOARES, H.D., PIERCE, J.E.S., et al. (1995). A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects. J. Neurotrauma 12, 169-178.
76. SMITH, S.E., LEKIEFFRE, P., SOWINSKI, P., and MELDRUM, B.S. (1989). Cerebroprotective effect of BW619C89 after focal and global cerebral ischaemia in rat. NeuroReport 32, 1339-1342.
77. SOARES, H.D., THOMAS, M., CLOHERTY, K., and McINTOSH, T.K. (1992). Development of prolonged focal cerebral edema and regional cation change following experimental brain injury in the rat. J. Neurochem. 58,s 1845-1852.
78. STUTZMANN, J.-M., BOHME, G.A., GANDOLFO, G., et al. (1991). Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat. Eur. J. Pharmacol. 193, 223-229.
79. STUTZMANN, J.-M., and DOBLE, A. (1995). Blockade of glutaminergic transmission and neuroprotection: The strange case of Riluzole, in: Neurodegenerative Disease. G. Jolles and J.-M. Stutzmann (eds.) Academic Press: Orlando, FL, pp. 205-214.
80. STUTZMANN, J.-M., PRATT, J., BORAUD, T., and GROSS, C. (1996). Riluzole's effect on post-traumatic spinal cord injury in the rat. NeuroReport In press.
81. SUN, F.-Y., and FADEN, A.I. (1995). Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury. Brain Res. 673, 133-140.
82. TAFT, W.C., YANG, K., DIXON, C.E., CLIFTON, G.L., and HAYES, R.L. (1993). Hypothermia attenuates the loss of hippocampal microtubule-associated protein 2 (MAP2) following traumatic brain injury. J. Cereb. Blood Flow Metab. 13, 796-802.
83. TORREGROSA, G., SALOM, J.B., ALABADI, J.A., MIRANDA, F. J., and ALBORCH, E. (1994). Evidence of a direct constrictor action of MK 801 and its modulation by the endothelium in cerebral arteries. J. Vasc. Res. 31, 221-229.
84. TOULMOND, S., SERRANO, A., BENAVIDES, J., and SCATTON, B. (1993). Prevention by Eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window. Brain Res. 620, 32-41.
85. VODDI, M.D., PERRI, B.R., PERLMAN, K.G., SMITH, D.H., LEACH, M., and MCINTOSH, T.K. (1995). The use-dependent sodium channel antagonist 619C89 attenuates memory dysfunction following experimental brain injury. J. Neurotrauma 12, 146.
86. ZHANG, R.L., CHOPP, M., CHEN, H., GARCIA, C.H., and ZHANG, Z.G. (1993). Postischemic hypothermia significantly reduces ischemic cell damage in rats subjected to 2 hours of middle cerebral artery occlusion. Stroke 24, 1235-1240.
87. ZOLA-MORGAN, S.M., and SQUIRE, L.R. (1986). Memory impairment in monkeys following lesions limited to the hippocampus. Behav. Neurosci. 100, 155-160.